Oncology - Medicine.net

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on: February 23,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on:February 23,2024

National cancer control efforts should address the system, not its individual parts, says new report

by National Academy of SciencesCredit: CC0 Public DomainCurrent cancer control efforts in the United States typically are fragmented and uncoordinated, but taking a systems approach to establish

Updated on: May 23,2024

National cancer control efforts should address the system, not its individual parts, says new report

by National Academy of SciencesCredit: CC0 Public DomainCurrent cancer control efforts in the United States typically are fragmented and uncoordinated, but taking a systems approach to establish

Updated on:May 23,2024

Acupressure versus acupuncture—which one is better at treating sleep disturbance in patients with cancer?

byWileyCredit: CC0 Public DomainBoth acupuncture—which is invasive and involves inserted needles—and acupressure—which is non-invasive and involves mechanical pressure—can potentially help reduc

Updated on: January 15,2024

Acupressure versus acupuncture—which one is better at treating sleep disturbance in patients with cancer?

byWileyCredit: CC0 Public DomainBoth acupuncture—which is invasive and involves inserted needles—and acupressure—which is non-invasive and involves mechanical pressure—can potentially help reduc

Updated on:January 15,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on: March 30,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on:March 30,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un

Updated on: January 07,2024

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un

Updated on:January 07,2024

Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

by Kelley Luckstein,Mayo ClinicCredit: CC0 Public DomainMayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patien

Updated on: February 01,2024

Researchers publish cell protein findings to determine effectiveness of immunotherapy for colon cancer

by Kelley Luckstein,Mayo ClinicCredit: CC0 Public DomainMayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patien

Updated on:February 01,2024

Genetic connection between aerobic fitness and disease is not what you'd expect

by American Physiological SocietyCredit:Physiological Genomics(2023). DOI: 10.1152/physiolgenomics.00026.2023New research examines the complex relationship between gene variants, card

Updated on: May 07,2024

Genetic connection between aerobic fitness and disease is not what you'd expect

by American Physiological SocietyCredit:Physiological Genomics(2023). DOI: 10.1152/physiolgenomics.00026.2023New research examines the complex relationship between gene variants, card

Updated on:May 07,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on: February 18,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on:February 18,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris